K

Korro Bio, Inc.

99 employees

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$116M

from 14 investors over 14 rounds

K

Korro Bio, Inc. raised $116M on January 5, 2022

Investors: MP Healthcare Venture Management Inc, Qiming Venture Partners USA, The Invus Group, Surveyor Capital, Sixty Degree Capital, Monashee Investment Management LLC, Point72 Asset Management and Wu Capital （双湖资本）

K

Korro Bio, Inc. raised $92M on September 10, 2020

Investors: Qiming Venture Partners USA, MP Healthcare Venture Management Inc, Surveyor Capital, Atlas Venture and Wu Capital （双湖资本）

K

Korro Bio, Inc. raised undisclosed on January 1, 2018

Investors: Atlas Venture